The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder-Reference-Cited by-同舟云学术

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

Published:2019-09-03 Issue:1 Volume:9 Page:
ISSN:2158-3188
Container-title:Translational Psychiatry
language:en
Short-container-title:Transl Psychiatry

Author:

Recourt Kasper,de Boer Peter,Zuiker Rob^ORCID,Luthringer Remy,Kent Justine,van der Ark Peter,Van Hove Ilse,van Gerven Joop,Jacobs Gabriel,van Nueten Luc,Drevets Wayne

Funder

Janssen Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health

Link

http://www.nature.com/articles/s41398-019-0553-z.pdf

Reference50 articles.

1. Ferrari, A. J. et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS ONE 8, e69637 (2013).

2. Whitmer, A. J. & Gotlib, I. H. Switching and backward inhibition in major depressive disorder: The role of rumination. J. Abnorm. Psychol. 121, 570 (2012).

3. Hatzinger, M., Hemmeter, U. M., Baumann, K., Brand, S. & Holsboer-Trachsler, E. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J. Psychiatr. Res. 36, 287–297 (2002).

4. Hatzinger, M., Hemmeter, U. M., Brand, S., Ising, M. & Holsboer-Trachsler, E. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response. J. Psychiatr. Res. 38, 453–465 (2004).

5. Bao, A.-M., Meynen, G. & Swaab, D. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 57, 531–553 (2008).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Circuit–Derived Biotypes for Treatment Selection in Mood Disorders: A Critical Review and Illustration of a Functional Neuroimaging Tool for Clinical Translation;Biological Psychiatry;2024-10

2. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease;Annual Review of Pharmacology and Toxicology;2024-01-23

3. Emerging and upcoming therapies in insomnia;Translational and Clinical Pharmacology;2024

4. Clinical specificity profile for novel rapid acting antidepressant drugs;International Clinical Psychopharmacology;2023-06-30

5. Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety;Molecules;2023-04-19